technetium tc 99m hydroxymethylene diphosphonate has been researched along with Cancer of Pelvis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cesnik, R; Frühwald, F; Leitha, T; Steiner, E | 1 |
| Farmer, KD; Franklin, K; Gellett, LR; Vivian, GC | 1 |
| Oates, E; Sarno, RC | 1 |
3 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Cancer of Pelvis
| Article | Year |
|---|---|
Use of FDG-PET in the differential diagnosis of a single bone lesion in ovarian cancer.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Pelvic Bones; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2004 |
Bladder diverticulum simulating a pelvic metastasis on a Tc-99m HDP bone scan.
Topics: Aged; Bone and Bones; Bone Neoplasms; Diagnosis, Differential; Diverticulum; Humans; Male; Pelvic Neoplasms; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Urinary Bladder Diseases | 2001 |
Imaging of pelvic rhabdomyosarcoma by bone scintigraphy.
Topics: Adolescent; Bone Neoplasms; Humans; Male; Pelvic Neoplasms; Radionuclide Imaging; Rhabdomyosarcoma; Technetium Tc 99m Medronate; Urinary Tract | 1987 |